217 related articles for article (PubMed ID: 25834528)
1. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.
Mugisha E; LaMontagne DS; Katahoire AR; Murokora D; Kumakech E; Seruyange R; Tsu VD
Afr Health Sci; 2015 Mar; 15(1):33-41. PubMed ID: 25834528
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
3. Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program.
LaMontagne DS; Nghi NQ; Nga le T; Janmohamed A; Huyen DT; Hien NT; Tsu VD
BMC Public Health; 2014 Jun; 14():556. PubMed ID: 24898950
[TBL] [Abstract][Full Text] [Related]
4. Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.
Rujumba J; Akugizibwe M; Basta NE; Banura C
PLoS One; 2021; 16(6):e0253735. PubMed ID: 34185805
[TBL] [Abstract][Full Text] [Related]
5. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
[TBL] [Abstract][Full Text] [Related]
6. Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda.
Nabirye J; Okwi LA; Nuwematsiko R; Kiwanuka G; Muneza F; Kamya C; Babirye JN
BMC Public Health; 2020 Feb; 20(1):171. PubMed ID: 32019543
[TBL] [Abstract][Full Text] [Related]
7. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
8. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
9. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
10. Introduction of a National HPV vaccination program into Bhutan.
Dorji T; Tshomo U; Phuntsho S; Tamang TD; Tshokey T; Baussano I; Franceschi S; Clifford G
Vaccine; 2015 Jul; 33(31):3726-30. PubMed ID: 26057136
[TBL] [Abstract][Full Text] [Related]
11. Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya.
Watson-Jones D; Mugo N; Lees S; Mathai M; Vusha S; Ndirangu G; Ross DA
PLoS One; 2015; 10(6):e0123701. PubMed ID: 26115523
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
[TBL] [Abstract][Full Text] [Related]
13. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
Egbon M; Ojo T; Aliyu A; Bagudu ZS
BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
[TBL] [Abstract][Full Text] [Related]
14. Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
Garon JR; Mukavhi A; Rupfutse M; Bright S; Brennan T; Manangazira P; An Q; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A30-A37. PubMed ID: 34144852
[TBL] [Abstract][Full Text] [Related]
15. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
Paul P; Fabio A
Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
[TBL] [Abstract][Full Text] [Related]
16. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings.
Bingham A; Drake JK; LaMontagne DS
Arch Pediatr Adolesc Med; 2009 May; 163(5):455-61. PubMed ID: 19414692
[TBL] [Abstract][Full Text] [Related]
17. Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders.
Vermandere H; Naanyu V; Degomme O; Michielsen K
BMC Public Health; 2015 Sep; 15():875. PubMed ID: 26358701
[TBL] [Abstract][Full Text] [Related]
18. Assessment of eight HPV vaccination programs implemented in lowest income countries.
Ladner J; Besson MH; Hampshire R; Tapert L; Chirenje M; Saba J
BMC Public Health; 2012 May; 12():370. PubMed ID: 22621342
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of human papillomavirus vaccination of adolescent schoolgirls in western Uganda and their implications for acceptability of HPV vaccination: a qualitative study.
Turiho AK; Okello ES; Muhwezi WW; Katahoire AR
BMC Res Notes; 2017 Aug; 10(1):431. PubMed ID: 28854964
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.
Nakayita RM; Benyumiza D; Nekesa C; Misuk I; Kyeswa J; Nalubuuka A; Murungi T; Udho S; Kumakech E
BMC Womens Health; 2023 Jul; 23(1):362. PubMed ID: 37420225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
